Australian trial offers hope to 1 in 70 Australians with coeliac
The Walter and Eliza Hall Institute is recruiting volunteers for a phase two trial of a drug that stops the immune response to gluten.
Why it mattersCoeliac disease is chronic and requires strict diet control. A drug that blocks the immune response could let sufferers eat normally again and greatly improve quality of life.
AustraliaOne in 70 Australians have coeliac disease, though only 20 per cent are diagnosed. This Australian-led breakthrough could transform life for hundreds of thousands of people, especially those unaware they have the condition.
Corroborated bythenightly.com.au
✓ Claims checked against the source. checked 35 min ago



